Communiqués

02/01/25 Avinger : Private Placement Form 8 K PU
08/11/24 Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q) PU
08/11/24 Avinger : Reports Third Quarter 2024 Results Form 8 K PU
07/11/24 Avinger: Q3 Earnings Snapshot AQ
25/10/24 Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention AQ
19/09/24 Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents AQ
08/08/24 Avinger: Q2 Earnings Snapshot AQ
30/07/24 Avinger to Announce Second Quarter 2024 Results on August 8, 2024 AQ
06/06/24 Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business AQ
15/05/24 Avinger: Q1 Earnings Snapshot AQ
20/03/24 Avinger: Q4 Earnings Snapshot AQ
27/11/23 Avinger : Failure to Satisfy Listing Rule - Form 8-K PU
26/10/23 Avinger: Q3 Earnings Snapshot AQ
05/10/23 Avinger : Shareholder Director Nominations - Form 8-K PU
28/09/23 Avinger Raises $5.3 Million via At-The-Market Facility AQ
20/09/23 Avinger : Material Event - Form 8-K PU
19/09/23 Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device AQ
25/08/23 Avinger Announces Presentations by Key Opinion Leaders at AMP 2023 AQ
27/07/23 Avinger: Q2 Earnings Snapshot AQ
23/05/23 Avinger : Failure to Satisfy Listing Rule - Form 8-K PU
22/05/23 AVINGER INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) AQ
10/05/23 Avinger: Q1 Earnings Snapshot AQ
26/04/23 Avinger : Regulation FD Disclosure - Form 8-K PU
26/04/23 AVINGER INC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) AQ
26/04/23 Avinger : Failure to Satisfy Listing Rule - Form 8-K PU
Aucun résultat pour cette recherche